Tag: stroke risk

1. Guided selection of antiplatelet therapy reduced rates of major adverse cardiovascular event rates compared to standard therapy. 2. Guided selection strategy was beneficial for both escalation and de-escalation of standard therapy, balancing patient-dependent ischemic and bleeding risks.  Evidence Rating Level: 1 (Excellent) Study Rundown: Patients who undergo percutaneous coronary intervention (PCI)...
1. Risk of recurrent stroke within 90 days of an index event was comparable among patients with non-consensus TIA and classic TIA. 2. Patients with non-consensus TIA were less likely to seek medical attention after the index event. Evidence Rating Level: 2 (Good) Study Rundown: The risk of stroke following a transient...